CREBBP and acute myeloid leukemia: Chromosomal aberrations disrupt CREBBP on chromosome 16p13, such as inv(16)(p13.1q22) or t(8;16)(p11;p13), usually resulting in AML with distinct morphological and clinical features6–8.